Detalles de la búsqueda
1.
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.
N Engl J Med
; 389(23): 2125-2139, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870968
2.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 436, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589856
3.
Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study.
Acta Oncol
; 63: 213-219, 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38647024
4.
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models.
Gastric Cancer
; 27(3): 473-483, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38261067
5.
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
Br J Cancer
; 128(7): 1391-1399, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36759721
6.
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy.
Br J Cancer
; 129(10): 1619-1624, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749283
7.
Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions.
Ann Surg
; 278(3): e540-e548, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453261
8.
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors.
Oncologist
; 28(9): 771-779, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37023721
9.
Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and Outcomes.
Ann Surg Oncol
; 30(1): 404-414, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094689
10.
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study.
Gastric Cancer
; 26(3): 425-437, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36881202
11.
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action.
Gastric Cancer
; 26(6): 958-968, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37382783
12.
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer.
Future Oncol
; 19(37): 2445-2452, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37701986
13.
The prognostic value of radiomic features in liver-limited metastatic colorectal cancer patients from the TRIBE2 study.
Future Oncol
; 19(23): 1601-1611, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37577810
14.
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.
Nature
; 552(7683): 116-120, 2017 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29186113
15.
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.
Gut
; 71(7): 1277-1288, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34433583
16.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35636444
17.
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial.
Int J Cancer
; 151(10): 1760-1769, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678328
18.
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study.
Int J Cancer
; 151(8): 1310-1320, 2022 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723131
19.
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
Br J Cancer
; 127(5): 957-967, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35665778
20.
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.
Br J Cancer
; 126(3): 449-455, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34811502